Verification register Bio, Health & Neuro
Current reading
The readiness gap, in one scan
AI-assisted assembly · derived results
- Claimed
- 35
- Reported
- 35
- Verified
- 30
- Gap
- +5
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed minus verified
Evidence strength Growing
Decision
What the current evidence supports
Human editorial judgment · 2026-06-28
Too early to adopt
- Why
- Two peer-reviewed primary results from independent groups (attomolar/picomolar sensitivity, 100% concordance on small cohorts) make the mechanism genuinely real, but validation is narrow (one virus, 31 samples for SLEUTH; 40 HCV samples for the companion) and therapeutic use is years out — no adoptable artifact exists today.
- Next
- Track the two May-2026 Nature Biotechnology papers and watch for independent replication, a multi-pathogen panel, and any in-cell/in-vivo therapeutic demonstration before treating as a usable platform
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 7
- Tier 1
- 0
- Tier 2
- 0
- Tier 3
- 7
- Supports
- 5
- Contradicts
- 2
- Context
- 0
- Latest observed
- 2026-05-18
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
This is the initial public reading. No earlier readiness change is recorded.